Golimumab (CNTO-148) is a potent humanized anti-TNFalpha IgG1kappa monoclonal antibody with anti-inflammatory and anticancer activity. It inhibits the production of IL-6 and IL-1beta, induces apoptosis, and can be used to prevent inflammation and destruction of cartilage or bone. This makes Golimumab valuable for studying rheumatoid arthritis and cancer.
Purity:
97.90%
CAS Number:
[476181-74-5]
Target:
Caspase|||Apoptosis|||TNF|||Interleukin
T76711
T76711
* VAT and and shipping costs not included. Errors and price changes excepted
